2 Indian Firms Seek To End Current Trials Of Merck's Anti-Covid Pill

https://ift.tt/eA8V8J
Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's experimental antiviral drug molnupiravir in moderate COVID-19 patients.

from October 08, 2021 at 11:42PM
NDTV News - Topstories https://ift.tt/3iFD1JW